Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
33 studies found for:    "Pemphigus"
Show Display Options
Rank Status Study
1 Terminated Efficacy and Safety of Ofatumumab in Treatment of Pemphigus Vulgaris
Condition: Pemphigus
Interventions: Biological: Ofatumumab;   Biological: Placebo
2 Terminated
Has Results
Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus
Condition: Pemphigus Vulgaris
Interventions: Drug: intravenous immunoglobulin;   Drug: cyclophosphamide
3 Completed Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris
Condition: Pemphigus Vulgaris
Intervention: Drug: Enbrel (Etanercept)
4 Unknown  Wound Dressings for Pemphigus and Pemphigoid
Conditions: Pemphigus;   Pemphigoid
Interventions: Device: Cotton gauze with petrolatum;   Device: Cellulose acetate with petrolatum;   Device: Nanocrystalline silver (Acticoat);   Device: Carboxymethylcellulose with ionic silver (Aquacel Ag)
5 Recruiting Study of Efficacy and Safety of VAY736 in Patients With Pemphigus Vulgaris
Condition: Pemphigus Vulgaris
Interventions: Drug: VAY736;   Drug: Placebo to VAY736
6 Terminated
Has Results
Evaluating Sirolimus to Treat Autoimmune Blistering Dermatosis Pemphigus
Condition: Pemphigus
Intervention: Drug: Sirolimus (formerly known as Rapamycin)
7 Completed European Trial of Adjuvant Oral Glucocorticoid Pulse Therapy in Pemphigus
Condition: Pemphigus
Intervention: Drug: dexamethasone (50mg 1dd6, 3 consecutive days/month)
8 Unknown  Treatment of Pemphigus Patients With Rituximab 1000mgX2 and Assessment of Immune Status Via Cylex
Condition: Pemphigus
Intervention: Drug: Rituximab
9 Completed Long-term Clinical and Biological Evaluation of Patients With Severe Forms of Pemphigus Treated by Rituximab
Condition: Pemphigus
Intervention: Drug: Rituximab
10 Active, not recruiting Comparative Study of Rituximab Versus Combination of Rituximab and Intravenous Cyclophosphamide in Severe Pemphigus
Condition: Pemphigus
Intervention: Drug: Rituximab and Cyclophosphamide IV
11 Terminated Long-Term Extension Study of Ofatumumab in Subjects With Pemphigus Vulgaris
Condition: Pemphigus
Interventions: Drug: Ofatumumab;   Drug: Acetaminophen/paracetamol;   Drug: Antihistamine (cetirizine or equivalent);   Drug: Prednisone/Prednisolone
12 Completed Azathioprine Versus Placebo in Pemphigus Vulgaris Treated With Prednisolone
Condition: Pemphigus Vulgaris
Interventions: Drug: Azathioprine;   Drug: Prednisone;   Drug: Placebo
13 Completed Effect of Anti CD20 in Pemphigus Desease
Condition: Pemphigus
Intervention: Drug: Mabthera
14 Completed
Has Results
Use of Infliximab for the Treatment of Pemphigus Vulgaris
Condition: Pemphigus
Interventions: Drug: Infliximab;   Drug: Prednisone;   Other: Placebo
15 Recruiting Identification of Vulnerability Factors in the Course of Pemphigus Patients
Conditions: Pemphigus;   Dermatological Disease
Intervention: Behavioral: psychological support and therapeutic education program
16 Completed Use of KC706 for the Treatment of Pemphigus Vulgaris
Condition: Pemphigus Vulgaris
Intervention: Drug: KC706
17 Completed Safety Study of PI-0824 to Treat Pemphigus Vulgaris
Condition: Pemphigus Vulgaris
Intervention: Drug: PI-0824
18 Terminated Efficacy of Dapsone as a Steroid Sparing Agent in Pemphigus Vulgaris
Condition: Pemphigus Vulgaris
Intervention: Drug: Dapsone
19 Active, not recruiting Comparison Between Rituximab Treatment and General Corticotherapy Treatment in Patients With Pemphigus
Condition: Pemphigus Disease
Interventions: Drug: General Corticotherapy;   Drug: Rituximab
20 Recruiting A Study of PRN1008 in Adult Patients With Pemphigus Vulgaris
Condition: Pemphigus Vulgaris
Intervention: Drug: PRN1008

   Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results    Last Page
Indicates status has not been verified in more than two years